Shanghai Haohai reports share capital stability, details repurchases

Shanghai Haohai Biological Technology Co., Ltd. has released its monthly return on movements in securities for September 2025. The report shows no changes in its registered share capital for both H and A shares during the month. The company's registered H share capital remains at RMB38,529,240, and its A share capital at RMB194,051,855, totaling RMB232,581,095.

Regarding issued shares, the number of H shares outstanding (excluding treasury shares) also held steady at 38,529,240. The company confirmed that 171,200 H shares, repurchased during September 2025, have not yet been canceled as of the reporting date.

The company also disclosed details concerning its 2021 Restricted A Share Incentive Scheme. No new shares were issued during the month. However, 1,440,000 Restricted Shares are eligible for granting to 204 participants, and 360,000 Restricted Shares to 93 participants, both at a grant price of RMB65.96 per A Share, subject to certain attribution conditions.